WallStreetZenWallStreetZen

NASDAQ: CAMP
Camp4 Therapeutics Corp Stock Ownership - Who owns Camp4 Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Camp4 Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard A. YoungDirector2025-09-1115,151$1.65
$25.00kBuy
Kelly GoldChief Financial Officer2025-09-116,060$1.65
$10.00kBuy
Josh MandelbrehmChief Executive Officer2025-09-116,060$1.65
$10.00kBuy
Yuri MaricichChief Medical Officer2025-09-116,060$1.65
$10.00kBuy
Amir NashatDirector2025-09-111,221,721$1.53
$1.87MBuy
Amir NashatDirector2025-09-1185,468$1.53
$130.77kBuy
Polaris Management Co VII LLC10% Owner2025-09-111,221,721$1.53
$1.87MBuy
Polaris Management Co VII LLC10% Owner2025-09-1185,468$1.53
$130.77kBuy
Andrew J. SchwabDirector2024-10-15909,090$11.00
$10.00MBuy
5am Partners VI LLC10% Owner2024-10-15909,090$11.00
$10.00MBuy

1 of 2

CAMP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAMP insiders and whales buy or sell their stock.

CAMP Shareholders

What type of owners hold Camp4 Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Enavate Sciences GP LLC18.78%3,785,802$10.52MInsider
Enavate Sciences GP LLC18.78%3,785,802$10.52MInstitution
5am Partners VI LLC14.52%2,927,915$8.14MInsider
5am Venture Management LLC14.52%2,927,915$8.14MInstitution
Andrew J. Schwab13.02%2,625,145$7.30MInsider
Northpond Ventures II GP LLC11.10%2,238,244$6.22MInsider
Ah Equity Partners Bio I LLC10.54%2,125,339$5.91MInsider
Ah Capital Management LLC10.54%2,125,339$5.91MInstitution
Harbourvest Partners LLC6.31%1,271,948$3.54MInstitution
Polaris Partners GP X LLC4.51%909,090$2.53MInsider

1 of 3

CAMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAMP40.59%59.41%Net BuyingNet Buying
HOWL42.70%57.30%Net Buying
ANL0.05%0.00%
INKT0.26%99.74%Net BuyingNet Buying
ACET62.39%19.44%Net Selling
View Top Biotech Stocks

Camp4 Therapeutics Stock Ownership FAQ

Who owns Camp4 Therapeutics?

Camp4 Therapeutics (NASDAQ: CAMP) is owned by 58.25% institutional shareholders, 85.27% Camp4 Therapeutics insiders, and 0.00% retail investors. Enavate Sciences GP LLC is the largest individual Camp4 Therapeutics shareholder, owning 3.79M shares representing 18.78% of the company. Enavate Sciences GP LLC's Camp4 Therapeutics shares are currently valued at $12.30M.

If you're new to stock investing, here's how to buy Camp4 Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.